Atlas Trials

A Study of PEG-somatropin Injection to Treat Children of Turner Syndrome

Clinical trial NCT03189160 · UNKNOWN

Trial details

NCT number
NCT03189160
Sponsor
Changchun GeneScience Pharmaceutical Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Turner Syndrome
Start date
2016-03-01
Primary completion
2018-03-01
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.